HBW Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


FDA Cosmetic Adverse Event Data Beg Question: Mandatory Reporting?

This article was originally published in The Tan Sheet

Executive Summary

Legislation to update cosmetics oversight would require companies to report serious adverse events, which could propel numbers upward while providing FDA with greater insight to the marketplace. According to FDA data, cosmetic-related AERs in 2015 more than tripled from 2009, with consumers doing most reporting.


Related Content

Mandatory AE Reporting In Supplement Space Offers Glimpse Of Possible Cosmetic Future
Feinstein, EWG Gunning For Spring Senate Hearing On Cosmetics Bill
FDA Cosmetics Update: 2013 AE Reports Tallied, 2014 Research Targeted





Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts